Pharmacogenetics of Clopidogrel: An Unresolved Issue.
Publication
, Journal Article
Pereira, NL; Geske, JB; Mayr, M; Shah, SH; Rihal, CS
Published in: Circ Cardiovasc Genet
April 2016
Duke Scholars
Published In
Circ Cardiovasc Genet
DOI
EISSN
1942-3268
Publication Date
April 2016
Volume
9
Issue
2
Start / End Page
185 / 188
Location
United States
Related Subject Headings
- Ticlopidine
- Thrombosis
- Stents
- Platelet Aggregation Inhibitors
- Pharmacogenetics
- Myocardial Infarction
- Middle Aged
- Male
- Humans
- Genotype
Citation
APA
Chicago
ICMJE
MLA
NLM
Pereira, N. L., Geske, J. B., Mayr, M., Shah, S. H., & Rihal, C. S. (2016). Pharmacogenetics of Clopidogrel: An Unresolved Issue. Circ Cardiovasc Genet, 9(2), 185–188. https://doi.org/10.1161/CIRCGENETICS.115.001318
Pereira, Naveen L., Jeffrey B. Geske, Manuel Mayr, Svati H. Shah, and Charanjit S. Rihal. “Pharmacogenetics of Clopidogrel: An Unresolved Issue.” Circ Cardiovasc Genet 9, no. 2 (April 2016): 185–88. https://doi.org/10.1161/CIRCGENETICS.115.001318.
Pereira NL, Geske JB, Mayr M, Shah SH, Rihal CS. Pharmacogenetics of Clopidogrel: An Unresolved Issue. Circ Cardiovasc Genet. 2016 Apr;9(2):185–8.
Pereira, Naveen L., et al. “Pharmacogenetics of Clopidogrel: An Unresolved Issue.” Circ Cardiovasc Genet, vol. 9, no. 2, Apr. 2016, pp. 185–88. Pubmed, doi:10.1161/CIRCGENETICS.115.001318.
Pereira NL, Geske JB, Mayr M, Shah SH, Rihal CS. Pharmacogenetics of Clopidogrel: An Unresolved Issue. Circ Cardiovasc Genet. 2016 Apr;9(2):185–188.
Published In
Circ Cardiovasc Genet
DOI
EISSN
1942-3268
Publication Date
April 2016
Volume
9
Issue
2
Start / End Page
185 / 188
Location
United States
Related Subject Headings
- Ticlopidine
- Thrombosis
- Stents
- Platelet Aggregation Inhibitors
- Pharmacogenetics
- Myocardial Infarction
- Middle Aged
- Male
- Humans
- Genotype